We address the needs of thousands of patients

Grifols strives to generate long-term sustainable value for all of its stakeholder groups, with a clear emphasis on patients and donors, whose generosity makes our plasma-derived therapies possible.

Therapeutic areas

Plasma and non-plasma therapies

Diagnostic solutions
Transfusional and Clinical

Immunology and Neurology

Immunodeficiencies and autoimmune disorders


Alpha-1 antitrypsin deficiency


Hemophilia and other bleeding and clotting disorders

Hepatology / Intensive Care

Hypovolemia and hypoalbuminemia in liver diseases, cardiac surgery, severe infection and other conditions.